Related Experiment Videos
Neonatal hypothalamic hamartoma: a differentiating nonlethal hamartoblastoma
Matthew A Saxonhouse1, Anthony T Yachnis, David J Burchfield
1Division of Neonatology, Department of Pediatrics, Shands Children's Hospital, University of Florida College of Medicine, Gainesville, Florida 32610-0296, USA. saxonma@peds.ufl.edu
Journal of Neurosurgery
|October 22, 2005
Summary
This study details a rare neonatal brain tumor, hypothalamic hamartoblastoma, in a patient with congenital anomalies. Despite its immature appearance, the tumor showed signs of differentiation, leading to a favorable prognosis without further treatment.
Area of Science:
- Neuro-oncology
- Developmental neuroscience
- Pediatric neurosurgery
Background:
- Hypothalamic hamartomas are rare congenital tumors.
- Hypothalamic hamartoblastoma is an immature variant with limited clinical data.
- Neonatal presentation of such tumors poses diagnostic and therapeutic challenges.
Observation:
- A neonate presented with a large hypothalamic hamartoma, cleft lip/palate, and seizures.
- Neuroimaging identified a significant extraaxial, intradural mass distorting the brainstem.
- Stereotactic biopsy revealed a cellular lesion with immature neuroepithelial cells.
Findings:
- Histopathology showed low proliferation (Ki67) but evidence of neuronal maturation (neuronal nuclear antigen expression).
- The lesion was consistent with hypothalamic hamartoblastoma.
- The patient exhibited a favorable clinical course over 2 years with no further intervention.
Implications:
- This case suggests hypothalamic hamartoblastoma can be a "differentiating" tumor with a good prognosis.
- Early diagnosis and careful monitoring are crucial for managing rare neonatal brain masses.
- Understanding tumor differentiation can guide treatment strategies and predict outcomes in pediatric neuro-oncology.